Hematologist with expertise in multiple myeloma, amyloidosis, hematopoiesis, stem cell transplantation, PNH, mathematical and computational modeling.
Joined September 2015
- Tweets57
- Following117
- Followers108
- Likes40
Congratulations to Dr Liu for her publication on macrophage/plasma cells/CAR-T interactions. frontiersin.org/articles/10.…
33
Just published: T cell redirecting therapy for multiple myeloma. Work with two remarkable advanced fellows in myeloma.
rdcu.be/eBhP2
David Dingli retweeted
Join us!
Join us in Lake Buena Vista, Florida (or via livestream) for Nephrology, Hypertension & Kidney Transplantation Update for the Clinician 2025. February 14-16, 2025: mayocl.in/40osJUP @MayoClinicNeph
David Dingli retweeted
More awareness=earlier diagnosis
MUST WATCH VIDEO: CLOSING THE MEDICAL EDUCATION GAP: The urgency to act is NOW
youtube.com/watch?v=A3jgmbNL…
Lack of awareness, a gap in medical education, is among the most critical and urgent challenges facing the amyloidosis community today. Raising awareness to accelerate diagnosis, coupled with available FDA-approved treatments, leads to a significant improvement in patient lives.
The Amyloidosis Speakers Bureau (ASB) brings the patient voice to medical education, complementing traditional didactic and clinical studies. Together, this narrows the education gap and results in a more robust and durable education of medical trainees, thereby accelerating diagnosis and improving patient lives.
Please WATCH this short powerful message from amyloidosis experts to medical educators.
At ASH2024 we presented data on FTIR/AI analysis of serum for early diagnosis of AL amyloidosis where timing is critical.
39
Proud of my continued collaboration with the team at Oncodea. We can distinguish between stable MGUS from@smoldering myeloma for proper risk stratification
45
David Dingli retweeted
Today Mayo Clinic announced the world's first known successful total larynx transplant performed in a patient with an active cancer as part of a clinical trial. This breakthrough paves the way for more treatment options and clinical trials. Read more: mayocl.in/3zBhUDI
Intravascular and Extravascular Hemolysis MoA in PNH ajmc.com/view/intravascular-… via @AJMC
43
David Dingli retweeted
Join @DingliMD December 8 for a satellite symposium on the latest data on the diagnosis and management of cold agglutinin disease (CAD).
Listen to what else David Dingli, MD, PhD has to say: pages.mycea.com/cco-sandiego…
David Dingli retweeted
Want the latest in #hematology? Join expert faculty for a free hematology symposium preceding the 65th ASH Annual Meeting in sunny San Diego. The best part? No ASH registration is required. See you there! 🌞 pages.mycea.com/cco-sandiego…
David Dingli retweeted
In a world first, the UK medicines regulator has approved a therapy that uses CRISPR gene editing as a treatment for diseases go.nature.com/3QPkzih
David Dingli retweeted
I am very happy to share a new preprint together with Iftikhar Ahmed, @david_dingli and @huang_weini that just came out
biorxiv.org/content/10.1101/…
In it we discuss how a hierarchical tissue structure changes clonal fitness over time.
David Dingli retweeted
Received the best news today! The #Carvykti Car-T cell therapy I completed at @MayoClinic last Friday was successful! I am in REMISSION!!! #multiplemyeloma #bloodcancer @david_dingli #mmrf – at Jeffersontown, KY
David Dingli retweeted
The booster we really need right now is to block infections and transmission
"We urgently need to achieve population-wide respiratory mucosa immunity" to break the chain of transmission of Covid and achieve containment of the virus
Our Operation Nasal Vaccine essay published @SciImmunology today
science.org/doi/10.1126/scii… an honor to work w/@VirusesImmunity
David Dingli retweeted
🌍 It's #MathOnco groups highlighting again: Today, we invite you to explore the Quantitative Personalized Oncology Lab by @HeikoEnderling at @MoffittNews in Tampa, Florida, USA. Check out the group: mathematical-oncology.org/pe… ⬇️
David Dingli retweeted
"91 is a much more mathematically interesting number than 90" - R. Penrose, 8th August 2022.
Today is Nobel laureate Roger's 91st birthday, so here is a picture of him taken an hour ago, shortly before he sat down to tea and cake and cosmology.
David Dingli retweeted
Why is a multiple myeloma patient never refractory to dexamethasone. After progressing through the last steroid regimen why do we punish them by continuing to give Them dexamethasone for the seventh regimen